Bristol Myers Squibb Co (BMY) Return on Invested Capital (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Return on Invested Capital for 18 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.

• In Q2 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Jun 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.02%, up 8.0% from the prior year.
• Return on Invested Capital climbed to 0.0% in Q2 2026 per BMY's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q1 2023 and bottomed at 0.02% in Q4 2024.
• Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2026.
• Annual changes were most pronounced in 2022 — Return on Invested Capital rose 2 bps — and 2024, when it declined 2 bps.
• Bristol Myers Squibb's Return on Invested Capital stood at 0.0% in 2022, then slumped by 39 bps to 0.0% in 2023, then tumbled by 1139 bps to 0.02% in 2024, then jumped by 87 bps to 0.0% in 2025, then gained by 23 bps to 0.0% in 2026.
• Business Quant data shows BMY's Return on Invested Capital at 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.